As Drones Become Critical Data Infrastructure, KULR Is Building the Power Layer Beneath Them

KULR Technology Group, Inc. (KULR) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. Item 2.01 Completion of Acquisition or Disposition of Assets During the period from August 20, 2026 through September 11, 2026, KULR Technology Group, Inc. (“KULR” or the “Company”) sold an aggregate of approximately 764 bitcoin (“BTC”) through a series of open market transaction

KULR Technology Group exited its Bitcoin mining and began selling its $BTC holdings after treasury volatility contributed to a $21.97 million net loss in Q2. The company recorded a $10.59 million non-cash Bitcoin fair-value loss, revenue fell 43% to $2.08 million. KULR repaid a Coinbase credit facility, reducing its BTC position to about 760.

KULR Technology Group, Inc. (KULR) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 KULR Technology Group Reports Second Quarter 2026 Financial Results HOUSTON / GLOBENEWSWIRE / August 13, 2026 / KULR Technology Group, Inc . (NYSE American: KULR) (the "Company" or "KULR"), a developer of safe, high-power energy systems that enable physical AI across

KULR Technology Group, Inc. (KULR) filed an SEC Form 8-K — Completion of Acquisition or Disposition of Assets. false 0001662684 0001662684 2026-07-20 2026-07-20 iso4217:USD xbrli:shares iso4217:USD xbrli:shares SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 Form 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earli

Ionis Pharmaceuticals (IONS) shares have fallen over 40% this year, despite analysts maintaining an average price target of $83.82. The company has six approved therapies, primarily for rare diseases, and is developing eight more in late-stage trials. Ionis reported a 40.7% revenue decline and a net loss in Q2, but analysts highlight its antisense oligonucleotide technology and potential for future growth.

GLOBALFOUNDRIES (GFS) secured $375M in CHIPS R&D funding and $300M for silicon photonics. Its stock rose 4.32% recently, but is down 46.67% over 90 days. Analysts value it at $76, 37% above its last close of $47.82, citing its global manufacturing and government incentives. However, risks include weak smartphone demand and high capital spending.